Skip to main content
Caplight Logo









OncoHelix Inc.

OncoHelix Inc.

Private
CalgaryHealthcare & Life Scienceshttps://www.oncohelix.org/

Last Round

Accelerator

Jan 1, 2025

Company Overview

OncoHelix Inc. is a precision diagnostics company that provides advanced molecular and immune diagnostic testing services to support personalized cancer care and clinical research.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision diagnosticscomprehensive genomic profilingCGPliquid biopsymolecular diagnosticspersonalized medicinepharmacogeneticsPGxcancer biomarker testingctDNA testinggenomic profilingclinical laboratorynext-gen sequencingNGSoncology diagnosticscompanion diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoHelix Inc. Comparables

Compare OncoHelix Inc. with similar companies based on industry and business-model similarity.

OncoHelix Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qualisure Diagnostics Inc.
83%
Nanostics Inc.
82%
OncoDNA
78%

OncoHelix Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 1, 2025
VC RoundSep 18, 2019

Key People

Founding team and executive leadership

Faisal Masood Khan

Chief Executive Officer

Executive Team

OncoHelix Inc. Investors

Notable investors and investment history

OncoHelix Inc. investors
InvestorRounds
University of CalgaryVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 31% MoM.

  • Apr 19, 2025

    Grew 33% QoQ, from 9 to 12 employees.

OncoHelix Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoHelix Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoHelix Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCalgary
Employee Range12
Year Founded2019
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?